Search Results - "Lankford, D. Alan"

Refine Results
  1. 1

    Continuous positive airway pressure (CPAP) changes in bariatric surgery patients undergoing rapid weight loss by Lankford, D Alan, Proctor, Charles D, Richard, Robert

    Published in Obesity surgery (01-03-2005)
    “…Obstructive sleep apnea (OSA) is a common condition in morbidly obese patients, with the reported prevalence ranging from 12-78%. There is increasing…”
    Get full text
    Journal Article
  2. 2

    Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy by Bogan, Richard K, Feldman, Neil, Emsellem, Helene A, Rosenberg, Russell, Lu, Yuan, Bream, Gary, Khayrallah, Moise, Lankford, D. Alan

    Published in Sleep medicine (01-09-2015)
    “…Highlights • JZP-110 is a wake-promoting agent with dopaminergic and noradrenergic activity. • JZP-110 resulted in greater changes in sleep latency on each…”
    Get full text
    Journal Article
  3. 3

    Tasimelteon for insomnia by Lankford, D Alan

    Published in Expert opinion on investigational drugs (01-07-2011)
    “…Insomnia is a prevalent disorder with nearly 50% of the US adult population reporting insomnia symptoms during the past year and 10 - 15% reporting chronic…”
    Get more information
    Journal Article
  4. 4

    Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder by Sangal, R Bart, Blumer, Jeffrey L, Lankford, D Alan, Grinnell, Todd A, Huang, Holly

    Published in Pediatrics (Evanston) (01-10-2014)
    “…To evaluate efficacy and safety of eszopiclone compared with placebo in children and adolescents with insomnia associated with attention-deficit/hyperactivity…”
    Get full text
    Journal Article
  5. 5

    Armodafinil: a new treatment for excessive sleepiness by Lankford, D Alan

    Published in Expert opinion on investigational drugs (01-04-2008)
    “…Armodafinil is a wake-promoting agent developed by Cephalon that was approved in mid-2007 for the treatment of excessive sleepiness associated with narcolepsy,…”
    Get more information
    Journal Article
  6. 6

    Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: A randomized, placebo‐controlled, 2‐way crossover polysomnography study by Roth, Thomas, Lankford, D. Alan, Bhadra, Pritha, Whalen, Ed, Resnick, E. Malca

    Published in Arthritis care & research (2010) (01-04-2012)
    “…Objective To assess the effect of pregabalin on polysomnographic (PSG) measures of sleep and patient‐rated sleep, tiredness, and pain in fibromyalgia patients…”
    Get full text
    Journal Article
  7. 7

    A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea by Colrain, Ian M, Black, Jed, Siegel, Lawrence C, Bogan, Richard K, Becker, Philip M, Farid-Moayer, Mehran, Goldberg, Rochelle, Lankford, D. Alan, Goldberg, Andrew N, Malhotra, Atul

    Published in Sleep medicine (01-09-2013)
    “…Abstract Objective We aimed to evaluate the impact of a novel noninvasive oral pressure therapy (OPT) (Winx®, ApniCure) system on polysomnographic measures of…”
    Get full text
    Journal Article
  8. 8

    A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance by Rosenberg, Russell P, Hull, Steven G, Lankford, D Alan, Mayleben, David W, Seiden, David J, Furey, Sandy A, Jayawardena, Shyamalie, Roth, Thomas

    Published in Journal of clinical sleep medicine (15-10-2014)
    “…To evaluate the effects of single doses of gabapentin 250 and 500 mg on polysomnographic (PSG) and participant-reported sleep measures in a 5-h phase advance…”
    Get full text
    Journal Article
  9. 9

    Low-Dose Sublingual Zolpidem Tartrate is Associated with Dose-Related Improvement in Sleep Onset and Duration in Insomnia Characterized by Middle-of-the-Night (MOTN) Awakenings by ROTH, Thomas, HULL, Steven G, LANKFORD, D. Alan, ROSENBERG, Russell, SCHARF, Martin B

    Published in Sleep (New York, N.Y.) (01-09-2008)
    “…To evaluate the efficacy and safety of low-dose, sublingual zolpidem tartrate when taken during a scheduled middle-of-the-night (MOTN) awakening in subjects…”
    Get full text
    Journal Article
  10. 10

    A Double-Blind, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness in Patients With Treated Obstructive Sleep Apnea and Comorbid Depression by KRYSTAL, Andrew D, HARSH, John R, YANG, Ronghua R, RIPPON, Gregory A, LANKFORD, D. Alan

    Published in The journal of clinical psychiatry (01-01-2010)
    “…Treatment of excessive sleepiness in the context of obstructive sleep apnea (OSA) may be particularly difficult in those with depression because depression…”
    Get full text
    Journal Article
  11. 11

    Effect of Gaboxadol on Sleep in Adult and Elderly Patients with Primary Insomnia : Results From Two Randomized, Placebo-Controlled, 30-Night Polysomnography Studies by LANKFORD, D. Alan, CORSER, Bruce C, ZHENG, Yan-Ping, ZHENGRONG LI, SNAVELY, Duane B, LINES, Christopher R, DEACON, Steve

    Published in Sleep (New York, N.Y.) (01-10-2008)
    “…To evaluate the efficacy and tolerability of gaboxadol in the treatment of adult and elderly patients with primary insomnia. Randomized, double-blind,…”
    Get full text
    Journal Article
  12. 12

    Efficacy and tolerability of indiplon in transient insomnia by Rosenberg, Russell, Roth, Thomas, Scharf, Martin B, Lankford, D Alan, Farber, Robert

    Published in Journal of clinical sleep medicine (15-06-2007)
    “…The efficacy of indiplon was evaluated by polysomnography (PSG) in an experimental model of transient insomnia consisting of the first night effect combined…”
    Get full text
    Journal Article
  13. 13

    Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial by Lydiard, R Bruce, Lankford, D Alan, Seiden, David J, Landin, Rick, Farber, Robert, Walsh, James K

    Published in Journal of clinical sleep medicine (15-07-2006)
    “…Indiplon is a nonbenzodiazepine GABA potentiator, which exhibits pharmacologic selectivity for GABA(A) receptors containing the alpha1 subunit. The aim of the…”
    Get more information
    Journal Article
  14. 14

    Wireless CPAP patient monitoring: accuracy study by Lankford, D Alan

    Published in Telemedicine journal and e-health (01-06-2004)
    “…The objective of this study was to evaluate the accuracy and reproducibility of a novel method for transmitting continuous positive airway pressure treatment…”
    Get more information
    Journal Article
  15. 15

    Posttraumatic narcolepsy in mild to moderate closed head injury by Lankford, D A, Wellman, J J, O'Hara, C

    Published in Sleep (New York, N.Y.) (01-12-1994)
    “…Scattered reports exist describing secondary narcolepsy that develops following disease or organic insult to the brain. The present study is concerned with one…”
    Get full text
    Journal Article
  16. 16

    Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients by Xyrem ® International Study Group

    Published in Sleep medicine (01-09-2005)
    “…To measure the effect of the nocturnal administration of sodium oxybate on cataplexy in patients with narcolepsy. This trial was conducted with 228 adult…”
    Get full text
    Journal Article
  17. 17

    A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy

    Published in Journal of clinical sleep medicine (15-10-2005)
    “…Assess the efficacy of sodium oxybate for the treatment of narcolepsy with an emphasis on excessive daytime sleepiness. Eight-week, multicenter, double-blind,…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations by Rose, R M, Castellani, S, Boeringa, J A, Malek-Ahmadi, P, Lankford, D A, Bessman, J D, Fritz, R R, Denney, C B, Denney, R M, Abell, C W

    Published in Psychiatry research (01-02-1986)
    “…Platelet monoamine oxidase (MAO B) in 59 normal and 57 RDC-diagnosed medicated and unmedicated schizophrenic subjects was analyzed for whole platelet and…”
    Get more information
    Journal Article